Primo Nutraceuticals Discusses Receipt of Medical Device Establishment License (MDEL) from Health Canada, Pivots to PPE

Primo Nutraceuticals Inc. (PRMO:CSE) (BUGVD: OTC) (FSE: 8BV) dedicated  to funding the rapid growth in production, processing, retail and  branding of cannabis and non-cannabis natural health products in Canada  and the United States. Primo has recently invested in several brands and is pursuing  partnerships with retailers and distribution companies in Canada and the  United States. Primo's management is in the process of building a corporate road map  to further vertically integrate the Company, specifically by way of the  “Primo”  & "Thrive," brands and a selection of curated partner  brands. Most recently Primo announced that it has received its Natural Product Number (NPN) and it has been issued a Medical Device Establishment License (MDEL) from Health Canada. Watch this interview or listen by Podcast on Apple, Google, Spotify or your favourite podcaster.